Literature DB >> 21791513

Non-cardiac surgery in patients with coronary stents: the RECO study.

Pierre Albaladejo1, Emmanuel Marret, Charles-Marc Samama, Jean-Philippe Collet, Kou Abhay, Olivier Loutrel, Hélène Charbonneau, Samir Jaber, Sophie Thoret, Jean-Luc Bosson, Vincent Piriou.   

Abstract

CONTEXT: Interruption or maintenance of oral antiplatelet therapy (OAT) during an invasive procedure may result in ischaemic and/or haemorrhagic complications. There is currently a lack of clear guidance regarding the issue of treatment interruption during surgical procedures.
OBJECTIVE: To evaluate the rate of major adverse cardiac and cerebrovascular events (MACCEs) and major or minor bleeding complications and their associated independent correlates in coronary stented patients undergoing urgent or planned non-cardiac surgery. DESIGN, SETTING, AND PATIENTS: Prospective, multicentre, observational cohort study of 1134 consecutive patients with coronary stents. MAIN OUTCOME MEASURES: The co-primary endpoints consisted of the incidence of MACCE and major bleeding within the first 30 days of an invasive procedure.
RESULTS: MACCE and haemorrhagic complications were observed in 124 (10.9%) and 108 (9.5%) patients, respectively, within an average time delay from invasive procedure to event of 3.3±3.9 and 5.3±5.3 days. Independent preoperative correlates for MACCE were complete OAT interruption for more than 5 days prior to surgery, preoperative haemoglobin <10 g/dl, creatinine clearance of <30 ml/min and emergency or high-risk surgery. Independent factors for haemorrhagic complications were preoperative haemoglobin <10 g/dl, creatinine clearance between 30 and 60 ml/min, a delay from stent implantation to surgery <3 months and high-risk surgery according to the Lee classification.
CONCLUSIONS: Patients with coronary stents undergoing an invasive procedure are at high risk of perioperative myocardial infarction including stent thrombosis irrespective of the stent type and major bleeding. Interruption of OAT more than 5 days prior to an invasive procedure is a key player for MACCE. CLINICAL TRIAL REGISTRATION: NCT01045850.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791513     DOI: 10.1136/hrt.2011.224519

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  24 in total

1.  Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

Authors:  Oleh Lushchak; Veronika Piskovatska; Olha Strilbytska; Iryna Kindrat; Nadya Stefanyshyn; Alexander Koliada; Volodymyr Bubalo; Kenneth B Storey; Alexander Vaiserman
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Antiplatelet therapy: Surgery should not interrupt treatment.

Authors:  Alexandra King
Journal:  Nat Rev Cardiol       Date:  2011-08-16       Impact factor: 32.419

3.  [Perioperative aspirin treatment in patients undergoing surgery: Perioperative Ischemic Evaluation 2 (POISE-2)].

Authors:  K Schrör; S Nitschmann
Journal:  Internist (Berl)       Date:  2014-12       Impact factor: 0.743

Review 4.  Percutaneous pleural drainage in patients taking clopidogrel: real danger or phantom fear?

Authors:  Katherine Linder; Oleg Epelbaum
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  [Comments on: perioperative administration of clonidine or aspirin].

Authors:  T A Treschan; P Kienbaum
Journal:  Anaesthesist       Date:  2014-06       Impact factor: 1.041

Review 6.  Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management.

Authors:  Davide Cao; Rishi Chandiramani; Davide Capodanno; Jeffrey S Berger; Matthew A Levin; Mary T Hawn; Dominick J Angiolillo; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2020-08-05       Impact factor: 32.419

7.  3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.

Authors:  Danielle Menosi Gualandro; Pai Ching Yu; Bruno Caramelli; André Coelho Marques; Daniela Calderaro; Luciana Savoy Fornari; Claudio Pinho; Alina Coutinho Rodrigues Feitosa; Carisi Anne Polanczyk; Carlos Eduardo Rochitte; Carlos Jardim; Carolina L Z Vieira; Debora Y M Nakamura; Denise Iezzi; Dirk Schreen; Eduardo Leal Adam; Elbio Antonio D'Amico; Emerson Q de Lima; Emmanuel de Almeida Burdmann; Enrique Indalecio Pachón Mateo; Fabiana Goulart Marcondes Braga; Fabio S Machado; Flavio J de Paula; Gabriel Assis Lopes do Carmo; Gilson Soares Feitosa-Filho; Gustavo Faibischew Prado; Heno Ferreira Lopes; João R C Fernandes; José J G de Lima; Luciana Sacilotto; Luciano Ferreira Drager; Luciano Janussi Vacanti; Luis Eduardo Paim Rohde; Luis F L Prada; Luis Henrique Wolff Gowdak; Marcelo Luiz Campos Vieira; Maristela Camargo Monachini; Milena Frota Macatrão-Costa; Milena Ribeiro Paixão; Mucio Tavares de Oliveira; Patricia Cury; Paula R Villaça; Pedro Silvio Farsky; Rinaldo F Siciliano; Roberto Henrique Heinisch; Rogerio Souza; Sandra F M Gualandro; Tarso Augusto Duenhas Accorsi; Wilson Mathias
Journal:  Arq Bras Cardiol       Date:  2017 Jan-Feb       Impact factor: 2.000

8. 

Authors:  André Arpad Faludi; Maria Cristina de Oliveira Izar; José Francisco Kerr Saraiva; Ana Paula Marte Chacra; Henrique Tria Bianco; Abrahão Afiune; Adriana Bertolami; Alexandre C Pereira; Ana Maria Lottenberg; Andrei C Sposito; Antonio Carlos Palandri Chagas; Antonio Casella; Antônio Felipe Simão; Aristóteles Comte de Alencar; Bruno Caramelli; Carlos Costa Magalhães; Carlos Eduardo Negrão; Carlos Eduardo Dos Santos Ferreira; Carlos Scherr; Claudine Maria Alves Feio; Cristiane Kovacs; Daniel Branco de Araújo; Daniel Magnoni; Daniela Calderaro; Danielle Menosi Gualandro; Edgard Pessoa de Mello; Elizabeth Regina Giunco Alexandre; Emília Inoue Sato; Emilio Hideyuki Moriguchi; Fabiana Hanna Rached; Fábio César Dos Santos; Fernando Henpin Yue Cesena; Francisco Antonio Helfenstein Fonseca; Henrique Andrade Rodrigues da Fonseca; Hermes Toros Xavier; Isabela Cardoso Pimentel Mota; Isabela de Carlos Back Giuliano; Jaqueline Scholz Issa; Jayme Diament; João Bosco Pesquero; José Ernesto Dos Santos; José Rocha Faria; José Xavier de Melo; Juliana Tieko Kato; Kerginaldo Paulo Torres; Marcelo Chiara Bertolami; Marcelo Heitor Vieira Assad; Márcio Hiroshi Miname; Marileia Scartezini; Neusa Assumpta Forti; Otávio Rizzi Coelho; Raul Cavalcante Maranhão; Raul Dias Dos Santos; Renato Jorge Alves; Roberta Lara Cassani; Roberto Tadeu Barcellos Betti; Tales de Carvalho; Tânia Leme da Rocha Martinez; Viviane Zorzanelli Rocha Giraldez; Wilson Salgado
Journal:  Arq Bras Cardiol       Date:  2017-07       Impact factor: 2.000

9.  Invited correspondence on: "Aspirin for patients undergoing major lung resections: hazardous or harmless?"

Authors:  Antje Messerschmidt; Davor Stamenovic
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 10.  The Periprocedural Management of Anticoagulation and Platelet Aggregation Inhibitors in Endoscopic Interventions.

Authors:  Christian M Lange; Stephan Fichtlscherer; Wolfgang Miesbach; Stefan Zeuzem; Jörg Albert
Journal:  Dtsch Arztebl Int       Date:  2016-02-26       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.